AVITA Medical Announces Achievement of Co-Primary Endpoints in Updated Analysis of Pivotal Trial of RECELL® System for Soft Tissue Repair | AVITA Medical
FDA Breakthrough Device Designations for VITILIGO & Soft Tissue for the RECELL® System, page-39
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.97 |
Change
-0.100(3.26%) |
Mkt cap ! $204.9M | |||
| Open | High | Low | Value | Volume |
| $3.05 | $3.06 | $2.97 | $828.7K | 276.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5504 | $2.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.98 | 5906 | 3 |
View Market Depth
| Last trade - 13.03pm 18/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |